CTM

Castellum, Inc. Announces 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
GAAP, Federation, Form 10-K, CTM, Security (finance), Cryptocurrency

BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.

Key Points: 
  • BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.
  • It is expected that audited financial results for 2023 will be disclosed in its Form 10-K which the Company expects to file with the Securities and Exchange Commission at www.sec.gov after the market closes today.
  • Management uses a Non-GAAP financial measure, Recurring Cash Operating Profit (“RCOP”), as an important measure of the Company’s operating performance.
  • See below for a full reconciliation of GAAP operating loss with non-GAAP recurring cash operating profit for Q4 2023.

Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank

Retrieved on: 
Friday, February 23, 2024
CTM, Security (finance), Live Oak Bank, Federation, Trust, BCR

BETHESDA, Md., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity and software services company focused on the federal government, announces that it has closed its previously announced $4 million financing with Live Oak Bank .

Key Points: 
  • BETHESDA, Md., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity and software services company focused on the federal government, announces that it has closed its previously announced $4 million financing with Live Oak Bank .
  • Castellum, Inc. ("Castellum") now has a $4 million revolving credit facility secured by cash, receivables, and the Company's other assets.
  • As part of the transaction, Castellum rolled over approximately $625,000 drawn down on its existing revolver with Live Oak Bank, paid down $400,000 owed to Robert Eisiminger, and paid down approximately $809,000 owed to the Buckhout Charitable Remainder Trust (the "BCR Trust").
  • "As we continue to amortize our existing term loan with Live Oak Bank, our debt/cash operating profit ratio keeps improving, and we position ourselves for a much brighter future.

MEC to X Solution Helps 5GtoB Achieve Closed-Loop Business Operations

Retrieved on: 
Monday, February 26, 2024
Cloud, RTT, Mobile, GSMA, Internet of things, Growth, Dou, Redcap, University, CTM, City, Huawei, University of Macau, LAN, MEC, Mobile phone

Against this backdrop, Huawei proposes the MEC to X solution powered by the Kite-Like Solution to construct local-area, wide-area, and cross-domain private networks.

Key Points: 
  • Against this backdrop, Huawei proposes the MEC to X solution powered by the Kite-Like Solution to construct local-area, wide-area, and cross-domain private networks.
  • This solution is able to shore up a variety of industries, lead their digital transformation, and help 5GtoB achieve business success.
  • The Kite-Like Solution, which upholds the concept of public network integrated non-public network (PNI-NPN), has been widely deployed for more than 40 industries in over 200 cities.
  • This solution helps build the nation's first 5G industry private network with the widest coverage and largest application.

R3 Continuum Report: Five Insights for Effective Workplace Mental Wellness Planning and Support

Retrieved on: 
Wednesday, February 14, 2024
Professional Services, DEI (Diversity, Equity and Inclusion), Mental Health, Health, Business, Telemedicine, Virtual Medicine, Human Resources, CTM, Mental health, HR, Workforce, Workplace, Multimedia, Doctor of Psychology, Organization, Face, ROI, Nursing

R3 Continuum , a workplace behavioral health company specializing in helping people and organizations thrive in the face of disruption, has released its inaugural 2024 Workplace Behavioral Health Report .

Key Points: 
  • R3 Continuum , a workplace behavioral health company specializing in helping people and organizations thrive in the face of disruption, has released its inaugural 2024 Workplace Behavioral Health Report .
  • The insights were informed by trusted market research and R3’s more than three decades of workplace mental wellbeing and behavioral health consulting experience.
  • Five key areas of opportunity that the report examines include:
    “HR leaders are aware that they need to provide more mental wellness support and resources for employees,” said George L. Vergolias , PsyD, CTM, chief clinical officer, R3 Continuum.
  • At a time when organizations are looking to effectively bolster mental wellness offerings, it’s critical that HR decision-makers understand the evolving landscape.

Castellum Announces Closing of $2.7 Million Registered Direct Offering

Retrieved on: 
Monday, January 29, 2024
Castellum, Prospectus, Form, Regulation D, Sale, Federation, CTM, S-3, Attention, Telephone, Exercise, Act, Growth, Security (finance)

The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant was $0.32.

Key Points: 
  • The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant was $0.32.
  • The warrants will become exercisable upon effectiveness of shareholder approval, expire five years from such approval date, and have an exercise price of $0.35 per share.
  • The gross proceeds to the Company from the registered direct offering and concurrent private placement were approximately $2.7 million before deducting the placement agent’s fees and other estimated offering expenses payable by the Company.
  • “Today’s announcement represents another important milestone for Castellum,” said Mark Fuller, President and CEO .

Castellum Announces Pricing of $2.7 Million Registered Direct Offering

Retrieved on: 
Thursday, January 25, 2024
Prospectus, Form, Regulation D, Sale, Federation, CTM, S-3, Telephone, Attention, Exercise, Act, Security (finance)

The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.32.

Key Points: 
  • The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.32.
  • The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $2.7 million before deducting the placement agent’s fees and other estimated offering expenses payable by the Company.
  • The offering is expected to close on or about January 29, 2024, subject to the satisfaction of customary closing conditions.
  • Maxim Group LLC is acting as the sole placement agent in connection with the offering.

Sertifi Partners with Leading Travel and Payment Companies to Ensure Frictionless Arrivals for Business Travelers

Retrieved on: 
Tuesday, November 28, 2023
System, Corporate travel management, Travel, CTM, Risk, Online shopping

Sertifi partners with leading travel and payment companies, including Amtrav, Corporate Travel Management (CTM), and Conferma Pay, to ensure the secure delivery of card information to hotels, creating a seamless arrival for business travelers.

Key Points: 
  • Sertifi partners with leading travel and payment companies, including Amtrav, Corporate Travel Management (CTM), and Conferma Pay, to ensure the secure delivery of card information to hotels, creating a seamless arrival for business travelers.
  • With a free Sertifi portal , any hotel can receive credit and virtual card information directly from these companies.
  • “We know receiving trustworthy card information securely and in advance of arrival is critical,” said Nick Stojka, co-CEO of Sertifi.
  • Are you a travel or payment company interested in integrating with Sertifi?

Castellum, Inc. Announces Execution of Debt Term Sheet

Retrieved on: 
Monday, November 27, 2023
Federation, CTM, Security (finance)

BETHESDA, Md., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it has signed a non-binding $4 million debt term sheet with a significant regional bank.

Key Points: 
  • BETHESDA, Md., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it has signed a non-binding $4 million debt term sheet with a significant regional bank.
  • The closing of the debt financing is subject to customary due diligence by the bank, including a field audit as well as the negotiation and execution of definitive loan documents.
  • “We are pleased to announce that we have signed a term sheet which, upon closing, will facilitate the partial paydown and extension of our 2024 debt maturities until 2025 or later,” said Mark Fuller, President and CEO of Castellum .
  • “We believe that this non-dilutive financing reflects our improving financial performance, strong backlog and pipeline, and excellent payment history on all our existing debt.

Biocytogen and CtM Bio Achieve Milestone Progress in Co-Developing a TCR-mimic Antibody-based Multi-Specific T Cell Engager Targeting WT1/HLA-A02

Retrieved on: 
Wednesday, December 27, 2023
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Other Health, AACR, Neoplasm, Ovarian cancer, Antibody, TCR, HKEX, Medication, WT1, CTM, Patient, Acute myeloid leukemia, Therapy, Bone marrow, Vaccine

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and CtM Biotech (Shanghai) Co., Ltd ("CtM Bio") today jointly announce that the development of a tri-specific T cell engager for an intracellular target achieved milestone progress.

Key Points: 
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and CtM Biotech (Shanghai) Co., Ltd ("CtM Bio") today jointly announce that the development of a tri-specific T cell engager for an intracellular target achieved milestone progress.
  • The incorporation of the T co-stimulatory signal for WT1-targeting T cell engager further gives it the best-in-class properties and first-in-class potential.
  • Dr. Yuelei Shen, President and CEO of Biocytogen, said, “Our collaborative efforts with CtM Bio have progressed rapidly, resulting in the identification of novel immunotherapies targeting WT1.
  • This rapid and effective development of multi-specific T cell engagers undoubtedly validates CtM Bio’s advanced T-cell engager technology, along with our expertise in discovering fully human TCR-mimic antibodies against intracellular targets.

Castellum, Inc. Announces Third Quarter Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Operating cost, CTM, NYSE American, Federation, Castellum

BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (the "Company") (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces highlights of its operating results for its third quarter ended September 30, 2023.

Key Points: 
  • BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (the "Company") (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces highlights of its operating results for its third quarter ended September 30, 2023.
  • Operating loss, inclusive of all non-cash and non-recurring charges, including a $6.9 million write-down of goodwill triggered by the Company's stock price, was $8.6 million.
  • Castellum, Inc.'s full financial results for the three and nine months ending September 30, 2023, will be published on Form 10-Q at www.sec.gov .
  • Our pipeline of business development opportunities continues to grow, as does the number of submitted proposals for new contract opportunities.